Physician profile
Roy A Schmidt
NPI 1538109855
$2,605.72
in general payments reported to CMS, 2019-2025
34 companies · $94.61 in 2025
The $94.61 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $463 · 2021: $474 · 2022: $469 · 2023: $421 · 2024: $108 · 2025: $94.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $406.45 | 2019-2025 | General - Pain Management |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $264.25 | 2019-2022 | |
| Tersera Therapeutics LLC | $244.23 | 2019-2023 | Prialt |
| Medtronic, INC. | $242.62 | 2021-2025 | Synchromedii |
| Collegium Pharmaceutical, INC. | $199.22 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $175.58 | 2023-2024 | Adthyza, Horizant, Horizant |
| Indivior INC. | $86.99 | 2019-2020 | |
| Redhill Biopharma INC. | $86.43 | 2021 | |
| Scilex Pharmaceuticals INC. | $86.21 | 2019-2020 | |
| Pfizer INC. | $74.88 | 2020-2021 | |
| Medtronic USA, INC. | $70.07 | 2019-2020 | |
| Si-Bone, INC. | $59.86 | 2019-2021 | |
| Stimwave Technologies Incorporated | $55.19 | 2022 | |
| Saol Therapeutics INC. | $54.71 | 2020 | |
| Nevro Corp. | $50.03 | 2022-2024 | Senza |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $47.85 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $41.95 | 2019 | |
| Biodelivery Sciences International, INC. | $37.18 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $34.02 | 2024 | Iovera, Zilretta |
| Flowonix Medical Incorporated | $31.97 | 2019-2020 | |
| Kaleo, INC. | $29.76 | 2019 | |
| Amneal Pharmaceuticals LLC | $25.07 | 2023 | Lyvispah |
| Assertio Therapeutics, INC. | $24.85 | 2019 | |
| Bioventus LLC | $21.21 | 2022 | |
| Orexo US, INC. | $19.25 | 2019 | |
| Vyera Pharmaceuticals, LLC | $18.39 | 2019 | |
| Almatica Pharma LLC | $17.63 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $15.81 | 2019 | |
| Daiichi Sankyo INC. | $15.80 | 2019 | |
| Relievant Medsystems, INC. | $15.47 | 2022 | |
| Piramal Critical Care | $14.70 | 2020 | |
| Mdd US Operations, LLC | $13.52 | 2020 | |
| Radius Health, INC. | $12.94 | 2021 | |
| Elutia, INC. | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.